Skip to main content

DayOne Stakeholder Forum

Invitation-Only Event

This exclusive, invitation-only forum is designed to facilitate thoughtful exchanges and strategic discussions in the healthtech and medtech industries.

The industry is entering an exciting phase, and DayOne is positioned to lead in this transformation. We are ready to embrace the future with renewed strategic direction. These changes will shape the evolution of DayOne as an initiative and a brand. Be among the first to hear about what’s ahead.

Why Attend?

  • Be Informed: Gain early insights into the strategic shifts shaping DayOne’s future and the developments influencing the industry.
  • Connect: Network with key investors, innovators, and industry leaders in healthcare.
  • Learn: Engage with thought leaders and explore the ideas driving DayOne’s evolution.
  • Stay tuned, thought leaders to be announced soon. We are curating an afternoon of meaningful discussions designed to provide insights into the future of health innovation. With limited spaces available, this is a unique opportunity to engage with the community and stay informed about DayOne’s next steps.
  • Program

    13:00

    Door Opening & Registration

    13:30

    Welcome

    • Ursula Costa, Director DayOne – Healthcare Innovation, Basel Area Business & Innovation
    • Caoimhe Vallely-Gilroy, Director Strategy DayOne, Basel Area Business & Innovation
    • Kaspar Sutter, Head of the Department of Economic, Social and Environmental Affairs of the Canton of Basel-Stadt

    13:40

    How pharma and medtech leaders are shaping the future of healthtech

    14:00

    A new era for DayOne: our strategic blueprint for innovation and collaboration

    • Ursula Costa, Director DayOne – Healthcare Innovation, Basel Area Business & Innovation
    • Caoimhe Vallely-Gilroy, Director Strategy DayOne, Basel Area Business & Innovation

    14:30

    Networking break

    15:00

    How can startups and pharma innovate (better) together?

    15:30

    From Seed to Scale: Investment trends shaping healthtech

  • Daniel Dillinger, Principal, redalpine
  • Jean-Pierre Pennacino, CFO and Vice-President, MedAlliance
  • Marc Cikes, Managing Director, Debiopharm Investment Fund
  • 16:00

    Exploring medtech’s strategic position and influence in the healthtech landscape

  • Carsten Laue, Managing Partner, M2care Venture Studio
  • Beat Lechmann, Director R&D Innovation EMEA and Early Innovation Partner J&J Innovation EMEA Medtech, Johnson & Johnson MedTech
  • Clémence Hermann, Business development manager, Spirecut
  • 16:30

    Closing remarks

    • Ursula Costa, Director DayOne – Healthcare Innovation, Basel Area Business & Innovation

    16:40

    Apero and Networking

    18:00

    End

    Notes

    For further information

    futher information